We hypothesized that PD-1+Tim-3+ CD8+ TILs acquire peptide-MHC complexes (pMHCs) from APCs through trogocytosis and become the target of tumor-reactive PD-1+Tim-3– CD8+ T cells. The gene discussed is PDCD1; the disease is neoplasm.